Search News Archives
Social Media
Will BRIC be the Savior for the Life Sciences and Medical Devices Sector? BioCity to develop BioHub at Alderley Park Willetts’ announcement underpins need for accountability in research Seal of Approval for Pepceuticals New Pipet-X™ Pipette Controller – Reliable, Easy & Comfortable to Use IDT and SGI-DNA Broaden Their Collaboration to Provide Synthetic DNA Products up to 2 Mbp New Portable SPECTROSCOUT XRF Analyzer - the Lab that Goes Anywhere Novel RNA detection reagent enables gene expression analysis in living cells
Not happy with your ion chromatograph? Switch to Metrohm now and save! Debunking Myths about Peak Area Response of Glycoprotein Oligosaccharides Thermo Fisher Scientific Introduces Next Generation Ion Chromatography Suppressor ACE SuperC18 Ultra-Inert Extended pH Stability UHPLC and HPLC Columns Solid Phase Microextraction (SPME) Specialty Vials and Seals Merck Millipore to Highlight Capabilities in LC-MS at ASMS Revolutionize your pipetting with the new Biohit Picus electronic pipette Easy, Reliable Weighing in Regulated Areas Phenom proX all-in-one desktop SEM Flash of inspiration in the shaft tunnel - IKA launches the new video for UTTD control The only Chromatography Autosampler you will ever need! JG Finneran Associates introduces the 96-Well Multi-Tier Microtiter Plate System (Patented) IC for the people – Metrohm celebrates 25 years of ion chromatography
For further information or to sign up to receive any of our E-Newsletters click here Hitachi launches 3rd generation Tabletop Microscope BioTek releases Cytation™3 Cell Imaging Multi-Mode Reader Easy to use imaging and analysis with cellSens 1.8 Bruker and SCiLS GmbH Announce an Exclusive Partnership for SCiLS Lab Software for MALDI Imaging Definiens Extends Functionality of Leading Image and Data Analysis Solutions for Digital Pathology Qualoupe LIMS from Two Fold Software helps contract testing laboratories grow and develop business Ocean Optics Launches Powerful New Spectroscopy Software Thermo Fisher Scientific launches intuitive online tool for automation platform configuration Boehringer Ingelheim Implements Titian’s Mosaic Software to Manage New Biological Entity Samples Waters Biopharmaceutical, Bioanalysis and Screening Solutions Now Shipping with UNIFI 1.6 Molecular Devices Introduces SoftMax Pro 6 GxP Microplate Data Acquisition and Analysis Software
|
New 3000-Molecule Add-on Complements the Industry Leading Maybridge HitFinder Collection of Drug-Like Screening Compounds
publication date: Jan 3, 2012
|
author/source: Alto Marketing Limited
 Thermo Fisher Scientific Inc., the world leader in
serving science, today announced Maybridge HitFinderTM-Plus, a collection
of 3,000 pre-plated drug-like screening compounds that is ideal for a variety
of drug discovery programs. The new library expands the industry leading Maybridge
HitFinder collection of 14,400 screening compounds and is available as
an "add-on" for current HitFinder users at reduced upgrade fees. Thermo Fisher created the new HitFinder-Plus collection using an industry standard clustering algorithm, based on standard Daylight Fingerprints and a Tanimoto level of 0.55, to select a statistically representative sample of the full 56,000 compound Maybridge Screening Collection. All compounds fit Lipinski Ro5 guidelines for "drug-likeness" and have a purity level of greater than 90 percent. They have also been selected to be non-reactive, ensuring fewer false positives and higher-quality results. When combined, the pre-plated Maybridge HitFinder and HitFinder-Plus collections contain more than 17,400 unique drug-like screening compounds, providing a large, but manageable library that is flexible enough for a range of drug discovery programs. These pre-selected, diverse collections are conveniently supplied as dry films in Thermo Scientific Matrix 96-shallow-well plates or 384-well microplates. For further convenience, users can view and assess the exact structures in each plate by browsing the collections online at www.chem.maybridge.com/hitfinder. This ensures that the process of identifying potential drug leads using Maybridge compounds is as easy and cost-effective as possible. For further information on this product, please visit www.maybridge.com. About Maybridge Maybridge, a Thermo Fisher Scientific brand, is well-known for highly innovative drug-like molecules and screening compounds for drug discovery and development. With products available for both lab and development scale, the Maybridge line features new heterocyclic and phenyl ring-based chemical building blocks, including a unique and expanding range of reactive intermediates. For more information about Maybridge brand products, visit www.maybridge.com or call +44 18 40 77 05 67. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of nearly $11 billion, we have approximately 37,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications. Visit www.thermofisher.com. |
June American Society for Mass Spectroscopy - Annual Conference (ASMS) 14th Annual Drug Discovery Leaders Summit 2013 Discovery Chemistry & Drug Design Congress 2013 5th Annual Drug Development Congress 2013 Single Cell Genomics & Transcriptomics Asia Congress 2013 Next Generation Sequencing Data Congress 2013 Malvern Instruments announces global agreement with Proveris Scientific Astronomy Researchers Relocate to Liverpool Science Park Fujifilm Diosynth Biotechnologies Commissions New Cell Banking Facility at Billingham, UK Site Malvern Instruments wins decisive victory over Wyatt Technology Corporation in US Court of Appeals |
